| Accession Number | 0001635088-26-000116 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 22, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President&Immunovant CEO | Common Shares | โ | Oct 20, 2026 | Sale | 185,856 | $35.09 | $6,521,687.04 | 1,413,298 | Direct | โ | View Details | |
President&Immunovant CEO | Common Shares | โ | Oct 20, 2026 | Sale | 14,144 | $35.42 | $500,980.48 | 1,399,154 | Direct | โ | View Details |